HCW Biologics Inc. (HCWB) Operating margin 2020–2025
HCW Biologics Inc. (HCWB) operating margin by fiscal year — reported operating income divided by reported revenue.
-24270.7%FY2025 · since FY2020: -142.1% → -24270.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -24270.7% | -23123.1 pp |
| FY2024 | -1147.6% | -242.6 pp |
| FY2023 | -905.0% | -680.6 pp |
| FY2022 | -224.3% | — |
| FY2020 | -142.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More HCWB financial trends
HCWB RevenueHCWB Net incomeHCWB Net marginHCWB Gross profitHCWB Gross marginHCWB Operating incomeHCWB Operating cash flowHCWB Free cash flowHCWB Capital expendituresHCWB Return on equityHCWB Stock buybacksHCWB Dividends paidHCWB Total assetsHCWB Total liabilitiesHCWB Shareholders’ equityHCWB overview →